Anterior segment inflammation and complications after cataract surgery in patients with pseudoexfoliation syndrome. Age-related cataract
Conditions
Interventions
Intervention 1: Interventional Group: In addition to routine care including chloramphenicol eye drops every 6 hours and betamethasone eye drops every 4 hours until one month after surgery, ketorolac (
Sponsors
Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 95 Years
Inclusion criteria
Inclusion criteria: Having Significant cataract (grade 3 and higher) and clinical signs of PEX. The patient should not be used systemic or inhaled NSAIDs within 1 week before surgery and the patients should not use the inhaled or systemic corticosteroids within 15 days after surgery
Exclusion criteria
Exclusion criteria: Having known hypersensitivity to any components of the NSAIDs uncontrolled chronic ocular or systemic inflammatory disease; a history of eye trauma and any retinal and macular disease, any intraocular complication during surgery (vitreous loss) The patient who must be treated with systemic anti-inflammatory medications for extensive inflammation following cataract surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of subjects with anterior chamber inflammation based on cell count (CELL) and percentage of subjects with anterior chamber inflammation based on protein content based on the rating of the San-working Group (0 to 4 degrees). Timepoint: 1, 3, 7 and 30 days after surgery. Method of measurement: Clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| The degree of opacity of the anterior capsule (ACO) (grade 0-4) and degree of opacity of the posterior capsule (PCO) (grade 0-4). Timepoint: 1,3,6 months postoperatively. Method of measurement: photo slit examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mitra Akbari
Guilan University of Medical Sciences
Outcome results
None listed